CAR-T cell Clinical Trials
5 recruitingBiologic
Phase 15Phase 23
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaB-cell Lymphoma
Shenzhen University General Hospital10 enrolled1 locationNCT07584889
Recruiting
Phase 1Phase 2
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
Diffuse Large B Cell LymphomaNon-Hodgkin Lymphoma
University of Texas Southwestern Medical Center30 enrolled1 locationNCT06768905
Recruiting
Phase 1
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaHepatocellular Cancer
National Cancer Institute (NCI)38 enrolled1 locationNCT05003895
Recruiting
Phase 1Phase 2
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital20 enrolled1 locationNCT07097207
Recruiting
Phase 1
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Advanced Breast Cancer
Shenzhen Celconta Life Science Co., Ltd.18 enrolled1 locationNCT06724835